John Castellani Speaks at #PhRMA14

John J. Castellani is President and Chief Executive Officer of the Pharmaceutical Research and Manufacturers of America (PhRMA), an organization that represents America’s leading biopharmaceutical research companies. 

Select a Contributor Response

Conversations:

How can we assure that the 340B program provides access to discounted medicines to the indigent and vulnerable patients the program was designed to serve?

View All Conversations

 

How can we assure that the 340B program provides access to discounted medicines to the indigent and vulnerable patients the program was designed to serve?

Test Name
Test Title, Test Company

Read biography×
This is a test modal

Eric Hargis on 340B

Submitted by Julie on

Living with cancer takes a toll on anyone, but it can be especially devastating for uninsured and low-income patients. That’s why the 340B Drug Pricing Program is such an important issue. Congress created this program in 1992 to help improve access to medical services for this population. The program works by providing discounted prescription drugs to hospitals and clinics that serve high numbers of uninsured, low-income patients.

Eric Hargis
,


SWHR on 340B

The Society for Women’s Health Research is the nation’s only nonprofit organization whose mission is to improve the health of all women through research, education and advocacy. We believe that the 340B program is vital to ensuring that indigent women in the United States have access to quality health care and medications. SWHR is concerned that a recent report seriously calls into question whether that mission is being realized.

SWHR
,


Jeffrey Gallagher at #PhRMA14

Jeffrey M. Gallagher
,


David Miller at #PhRMA14

David Miller
,


Pages

Subscribe to PhRMA RSS